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Abstract
Taking into account our previous studies on cytotoxic metal compounds, new copper complexes with 3-aminoquinoxaline-2-carbo-
nitrile N1,N4-dioxide derivatives as ligands were synthesized and characterized by diﬀerent spectroscopic methods. The hypoxic selective
cytotoxicity towards V79 cells and the superoxide dismutase-like activity of the complexes were determined and related to physicochem-
ical properties of the compounds. In particular, the copper(II) complex with 3-amino-6-chloro-7-ﬂuoroquinoxaline-2-carbonitrile N1,N4-
dioxide showed cytotoxic selectivity in hypoxia being the most lipophilic compound of the series. On the contrary, the complex with
3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide was cytotoxic but not selective and that with 3-amino-7-chloro-6-methoxy-quinoxa-
line-2-carbonitrile N1,N4-dioxide was not cytotoxic towards V79 cells neither in oxia nor in hypoxia in the assayed conditions. The
rm Hammett substituent electronic descriptor was related to the eﬀect in hypoxic conditions and the SOD-like activity was correlated
to the eﬀect in normoxia.
 2007 Elsevier Inc. All rights reserved.
Keywords: Copper complexes; Quinoxaline N1,N4-dioxides; Hypoxia selective cytotoxins; Antitumor agents
1. Introduction
One general strategy for the research on new anticancer
agents has been the therapeutic use of metal containing
compounds [1,2]. Specially, in the search of less toxic
metal-based antineoplastic drugs, essential metal com-
plexes such as copper-based drugs have been developed [3].
The cytotoxicity of these complexes can be explained by
diﬀerent mechanisms of action. In particular, the report by
Oberley and Buettner showed that cancer cells have a less
than normal superoxide dismutase (SOD) activity and the
treatment with bovine native Cu-SOD decreased the growth
of several solid tumors [4]. As a consequence a variety of
copper complexes presenting SOD-like activity were exam-
ined for anticancer activity [3]. For instance, [Cu(II)(3,5-
diisopropyl salicylate)2] shows important SOD-like activity
and can be used for the diﬀerentiation of cultured cancer
cells from normal cells at concentrations that do not cause
cell death [5,6]. Besides, it has been reported that complexes
with SOD-mimetic action activate H2O2 to give reactive
radical species such as hydroxyl radical (OHÆ) that present
high biocidal potency [7,8].
On the other hand, copper(II) complexes with amino
acids [9], casiopeines [10], oligopeptides [11,12], mono-
and bis-thiosemicarbazones [5,13], among others, have
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been reported to be eﬀective cytotoxins in tumor models as
well as in tumor cell cultures.
Most of these copper complexes have biologically inac-
tive ligands but several of them contain bioactive organic
compounds that act in a diﬀerent way. Another advantage
of using copper ion as central metal is the possibility of
employing radioactive isotopes which can provide an addi-
tional antitumoral mechanism of action [14].
Looking for new strategies for the design of cytotoxic
molecules, well known bioreductive compounds that are
selectively activated under hypoxic conditions by cellular
reductases were developed. The hypoxic cells in solid
tumors live in a more favorable environment for reductive
reactions than those which are well oxygenated. In these
conditions bioreductive prodrugs would be activated
through a reductive mechanism in the absence of oxygen
and could become signiﬁcantly more toxic for hypoxic cells
than for well-oxygenated ones. In particular, several het-
erocyclic N-oxides and related compounds such as quinox-
aline N-dioxide derivatives can be reduced in hypoxic
conditions forming cytotoxic species that have the DNA
as main biological target [15–17].
As part of our research program involving metal com-
plexes with potential activity as chemotherapeutics, we
have previously developed new copper(II) and vanadyl
complexes as selective hypoxic cytotoxins (Fig. 1) trying
to improve the bioavailability and the pharmacological
and toxicological properties of the 3-aminoquinoxaline-2-
carbonitrile N1,N4-dioxide derivatives, ligands which have
proved to act as bioreductive compounds [18–20].
In these ﬁrst series, the cytotoxicity in hypoxia of these
complexes was similar or slightly better than that of the
free ligands whereas under well-oxygenated conditions
the complexes were almost non cytotoxic [20,21].
Taking into account these antecedents, in this work we
describe the development of a new series of Cu(II) com-
plexes but with non- and di-substituted 3-aminoquinoxa-
line-2-carbonitrile N1,N4-dioxide derivatives, trying to
improve bioactive proﬁle of these hypoxia selective cyto-
toxins and to get a metal–ligand synergism. Besides, we
present the SOD-like activity of the complexes with the
aim of detecting potential correlations with cytotoxicity
in normoxia. Consequently, we performed the synthesis,
analytical and spectroscopic characterization, and bio-
chemical and biological evaluation of three new Cu(II)
complexes of general formulae [CuII(H2O)x(L-H)2], where
L are the 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide
derivatives shown in Fig. 2 and L–H the deprotonated
ligands.
2. Experimental
2.1. Synthesis
All starting materials were commercially available
research-grade chemicals and were used without further
puriﬁcation.
Each ligand (L) (0.15 mmol) was sonicated in dried eth-
anol until total dissolution. To the resulting solution
20.0 mL of an ethanolic solution of CuSO4 Æ 5H2O
(0.075 mmol) were added. After stirring for half an hour,
a purple precipitate was formed, then ﬁltered, washed with
small portions of ethanol and dried at room temperature.
The stoichiometries of the compounds were [Cu(L1–
H)2] (code Cu–L1), [Cu(L2–H)2] (code Cu–L2) and
[Cu(L3–H)2(H2O)] (code Cu–L3) (L–H are the deproto-
nated ligands) and the yields were 53.2%, 41.2% and
39.4%, respectively. The results of the elemental analysis
(%) obtained with a Carlo Erba EA 1108 analyzer were:
Cu–L1 (C18N8H10O4Cu) Found/Calc.: C, 46.17/46.41; N,
23.94/24.05; H, 2.49/2.16; Cu–L2 (C18H6F2Cl2N8O4Cu)
Found/Calc.: C, 37.98/37.88; N, 19.35/19.63; H, 1.08/
1.06; Cu–L3 (C20N8H14O7Cl2Cu) Found/Calc.: C, 39.62/
39.18; N, 17.92/18.28; H, 1.96/2.29. IR (KBr) (m/cm1 for
Cu–L1, Cu–L2 and Cu–L3, respectively): 3386, 3362 and
3386 (N–H); 1575 and 1593, 1573 and 1595, and 1562
and 1584 (C@N! O), 2221, 2231 and 2228 (C„N). For
Cu–L3: 1340 (N! O).
2.2. Conductimetric and thermogravimetric measurements
Conductimetric measurements using a Conductivity
Meter 4310 Jenway were performed at 25 C in a DMF
solution (104 M), solvent that allow to determine the elec-
trolyte type of conducting complex (number of ions per
molecule of complex) [22] and in a DMSO solution
(104 M) for studying the stability of the complexes in
the solvent used in the cytotoxic studies.
Thermogravimetric measurements were obtained with a
Shimadzu TGA 50 thermobalance, with a platinum cell,
working under ﬂowing air (50 mL min1) and at a heating
rate of 6 C min1 and 0.5 C min1.
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Fig. 1. Hypoxia selective metal compounds with quinoxaline N1,N4-
dioxide derivatives where one of the aryl substituent is a H atom and the
other is those speciﬁed in the ﬁgure.
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Fig. 2. 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxides used as ligands.
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2.3. Spectroscopic measurements
Low-temperature (120 K) EPR experiments were per-
formed using a Varian E109 spectrometer equipped with a
rectangular cavity. To perform the experiments on solu-
tion-state samples, powder samples of the titled complexes
were dissolved in DMSO. The solution-state sample was
then centrifuged, and the supernatant was drawn in a quartz
sample tube for low-temperature EPR experiments. General
experimental conditions were: microwave power, 40 mW;
modulation amplitude, 4.0 G; modulation frequency,
100 kHz. The g-values were obtained by means of spectral
simulation using the software package EasySpin [23].
IR spectra, in the range between 4000 and 200 cm1,
were recorded on a Bomem M 102 FTIR spectrophotome-
ter using the KBr pellet technique. Electronic spectra of the
complexes were registered on a Shimadzu UV-1603 spec-
trophotometer in nujol suspension and DMSO solution.
Routine FAB+ spectra of the metal complexes have
been measured with a TSQ spectrometer (Finnigan) with
nitrobenzylalcohol as matrix. The ion gun was operated
at 8 kV and 100 lA (probe temperature: 30 C). Xenon
was used as primary beam gas.
2.4. Lipophilicity test
Lipophilicity tests were performed determining the par-
tition coeﬃcient between n-octanol and physiological solu-
tion [24]. The concentration of the compounds in the
physiological solution before and after the contact with
n-octanol was determined by atomic absorption spectrom-
etry using a Perkin Elmer 5000 equipment with an iron
Photron lamp, k = 324.8 nm and acetylene/air ﬂame. All
tests were run in duplicate.
2.5. Stability test
Thin layer chromatography was performed on pre-
coated silica gel 60 F 254 TLC plates (Aldrich). The copper
complexes were dissolved in DMSO and diluted with phos-
phate buﬀer (NaH2PO4, 50 mM), pH = 7.4 at 37 C until
the concentration reached 104 M (1% DMSO). These
solutions were kept at room temperature during 24 h
before application on the plates. The elution was per-
formed with chloroform for Cu–L1, chloroform:methanol
(90:10, v/v) for Cu–L2, and dichloromethane:methanol
(95:5, v/v) for Cu–L3 and the spots were located under
UV light and compared with those of the free ligands.
2.6. Cytotoxic studies
The complexes were tested for cytotoxicity to V79 cells
(Chinese hamster lung ﬁbroblasts) under hypoxic and aer-
obic conditions using a cloning assay, at a single dose, as
previously described [20,21,25–28].
The cells were obtained from ECACC (European Collec-
tion of Animal Cell Cultures) and maintained in logarith-
mic growth as subconﬂuent monolayers by trypsinization
and subculture to (1–2) · 104 cells/cm2. These operations
were performed twice weekly. The growth medium was
EMEM (Eagle’s Minimal Essential Medium), containing
10% (v/v) fetal bovine serum (FBS) and penicillin/strepto-
mycin at 100 U/100 lg/mL. Monolayers of V79 cells were
trypsinized, and suspension cultures were set up in 50 mL
glass ﬂasks: 2 · 104 cells/mL in 30 mL of EMEM contain-
ing 10% (v/v) FBS and HEPES (10 mM). The glass ﬂasks
were submerged and stirred in a water bath at 37 C, where
they were gassed with humidiﬁed air or pure nitrogen. Com-
pound solutions were prepared just before dosing. Stock
solutions, 150-fold more concentrated, were prepared in
pure DMSO (Aldrich) or sterilized distilled water. Thirty
min after the start of gassing, 0.2 mL of the stock com-
pound solution was added to each ﬂask (two ﬂasks per
dose). In every assay there was one ﬂask with 0.2 mL of
DMSO (negative control) and another with 7-chloro-3-[3-
(N,N-dimethylamino)propylamino]-2-quinoxalinecarbonit-
rile 1,4-dioxide hydrochloride (positive control). After 2 h
exposure to the compound, the cells were centrifuged and
resuspended in plating medium (EMEM plus 10% (v/v)
FBS and penicillin/streptomycin). Cell numbers were deter-
mined with a haemocytometer and 102–103 cells were plated
in 6-well plates to give a ﬁnal volume of 2 mL/30 mm of
well. Plates were incubated at 37 C in 5% CO2 for 7 days
and then stained with aqueous crystal violet. Colonies with
more than 64 cells were counted. The plating eﬃciency (PE)
was calculated by dividing the number of colonies by the
number of cells seeded. The percent of control-cell survival
for the compound-treated cultures (SFair and SFhypox)
was calculated as PEtreated/PEcontrol · 100. The compounds
were tested at 20.0 lM in duplicate ﬂasks, both in aerobic
and hypoxic conditions.
The compound which gave a low surviving fraction in
hypoxia was tested at diﬀerent doses in normoxia and
hypoxia. Two dose–response curves were obtained by plot-
ting the Sfair and Sfhypox at each concentration tested.
The potency values P (dose which gives 1% cell survival
in hypoxia or normoxia), and the hypoxic cytotoxicity ratio
HCR (ratio between doses in air and hypoxia giving the
same cell survival (1%)), were calculated.
2.7. Determination of SOD-like activity
Superoxide dismutase (SOD)-like activity was investi-
gated using Beauchamp and Fridovich’s method – as
improved by Imanari et al. [29]. This method is based on
the inhibitory eﬀect of SOD on the reduction of nitroblu-
etetrazolium (NBT) by the superoxide anion generated by
the xanthine/xanthine oxidase system. The solutions of
the complexes were prepared in DMSO before adding the
carbonate–bicarbonate buﬀer (Na2CO3, 33 mM; NaHCO3,
17 mM), pH = 10.2 at 37 C. For comparative purposes,
the activity of native superoxide dismutase from bovine
erythrocytes has also been determined. All the reagents
used in this assay were purchased from SIGMA.
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3. Results and discussion
3.1. Spectroscopic measurements
3.1.1. EPR spectra
X-band (9.1 GHz) EPR spectra of Cu–L1, Cu–L2, and
Cu–L3 in polycrystalline samples at 120 K are shown in
Fig. 3. These spectra are characteristic of exchange coupled
Cu(II) pairs showing, besides the usual resonance around
320 mT (g  2), an extra peak at ca. 160 mT (see insets in
Fig. 3), which is assigned to the so-called half-ﬁeld transi-
tion. The latter corresponds to DMs = 2 transition between
the Ms = 1 and Ms = +1 states of the triplet (S = 1) in a
system containing two S = 1/2 spins [30]. The absence of a
hyperﬁne structure, due to the interaction of the electron
spin S = 1/2 with the nuclear spin I = 3/2 of Cu(II) ions,
is also indicative of an exchange coupled regime between
the metal ions. The g-values determined from spectral sim-
ulations (Fig. 3) indicate a slightly distorted axial symmetry
and a similar structural environment around the Cu(II)
center in all complexes. Besides, linewidhts are somewhat
larger for Cu–L3. This increase in the widths leads to broad
lines and thus lower resolution for the shoulder around
300 mT, which cannot be distinguished from the resonance
at ca. 315 mT (gx and gy) for Cu–L3 complex.
The low-temperature EPR spectra of the complexes dis-
solved in DMSO were also measured (Fig. 4). In all cases, a
feature worth mentioning is the lack of the resonance asso-
ciated with the half-ﬁeld transition (around 160 mT – see
inset in Fig. 4). This is indicative that in the solution state
the complexes exist as monomers as previously observed
for other copper compounds [21,31]. Simulations of the
solution-state spectra yielded somewhat diﬀerent g-values
for Cu–L1 (gx = 2.035, gy = 2.105, gz = 2.300) when com-
pared to the values obtained from the solid-state sample.
There is a change in the local symmetry experienced by
the paramagnetic center that is now fully rhombic for the
Cu–L1 complex in the solution state. This is probably
due to the addition of DMSO in the copper environment.
The g-values calculated for compounds Cu–L2 and Cu–
L3 were approximately equal in both solid- and solution-
state (Cu–L2: gx = 2.050, gy = 2.055, gz = 2.208; Cu–L3:
gx = 2.050, gy = 2.050, gz = 2.250) indicating similar local
environments around the copper ions in these cases. The
main diﬀerence found in the solid-state as compared to
the solution-state EPR spectra of Cu–L2 and Cu–L3
resided in the narrow linewidths needed to achieve a rea-
sonable ﬁt of the experimental data in the solution-state.
This is expected if, upon dilution, we change from an inter-
mediate exchange coupling regime, which exists in solid-
state and leads to a broadening phenomenon, to a situation
where the copper ions are no longer coupled to each other
150 200 250 300 350
100 150 200
100 150 200
100 150 200
Magnetic field (mT)
(C) Cu-L3
gx = 2.050
gy = 2.055
gz = 2.230
gx = 2.050
gy = 2.055
gz = 2.208
(B) Cu-L2
(A) Cu-L1
gx = 2.050
gy = 2.055
gz = 2.208
Fig. 3. X-band EPR spectra (upper traces) of polycrystalline sample of
Cu–L1, Cu–L2 and Cu–L3 and their respective simulations (lower traces)
obtained using the EasySpin software. The insets show the resonance
associated with the half-ﬁeld transition (see text for discussion). The
g-values calculated from the simulations are also shown.
125 150 175
125 150 175
125 150 175
240 280 320 360 400
(C) Cu-L3
(B) Cu-L2
(A) Cu-L1
Magnetic field (mT)
Fig. 4. X-band EPR spectra (upper traces) of frozen solution samples of
Cu–L1, Cu–L2 and Cu–L3 and their respective simulations (lower traces)
obtained using the EasySpin software.
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as suggested by the lack of the half-ﬁeld transition in the
insets of Fig. 4. The same behavior concerning the line-
widths is also observed for Cu–L1 complex.
3.1.2. Infrared spectra
The IR spectra of the complexes were compared with
those of the free ligands and previously reported complexes
[18–21,32].
All the complexes showed a similar spectral pattern.
After the coordination the ligand bands corresponding to
ma (NH2)(In 3353–3380 cm
1 range) and ms (NH2)(In
3228–3288 cm1 range) of the amino group disappeared
and only one band was observed (3362–3386 cm1). This
is in accordance with the presence of a secondary amine
formed by deprotonation of the primary amine as a conse-
quence of the coordination with copper ion. This behavior
was previously observed for vanadyl and copper complexes
with this family of ligands, and for metal chelates with aro-
matic ligands involving the amino group in ortho position
to the N-oxide [18–21,33]. Furthermore, the strong
m(N! O) band for the free ligands (1338–1350 cm1)
turned weak upon complexation for Cu–L3 and shifted
in the case of Cu–L1 and Cu–L2. In the ﬁrst case this
behavior could be explained by the coordination of one
N! O group per ligand molecule keeping the other unco-
ordinated as shown in Fig. 5. In the case of Cu–L1 and Cu–
L2 the disappearance in the corresponding range of the
strong m(N! O) band was probably due to the fact that
the uncoordinated N! O groups have additional interac-
tions with other copper atoms from neighboring molecules,
which form intermolecular bonds in the solid state. This
behavior was previously observed in related complexes
[21]. The m(C„N) (2221–2238 cm1) suﬀered only minor
changes upon complexation in agreement with the fact that
this group did not coordinate to copper ion.
3.1.3. Electronic spectra
All ligands’ nujol spectra showed one band in the 480–
490 nm range. Upon coordination, these bands shifted to
higher wavelength: Cu–L1 (536 nm), Cu–L2 (526 nm) and
Cu–L3 (533 nm). Besides, all the complexes showed a d–d
broad band in the 572–582 nm range characteristic of
Cu(II) in a distorted octahedral geometry [34]. Possibly,
this behavior is due to the fact that in the crystal packing
there is another quinoxaline molecule as sixth ligand inter-
acting with the copper ion, in addition to those shown in
Fig. 5. This behavior was previously reported for similar
complexes [21]. In DMSO solutions these two bands were
not resolved and only a very broad band was observed in
the range 502–602 nm. This result does not allow us to
obtain information about the decomposition of the dimeric
unit observed by EPR measurements in solution.
3.1.4. FAB-MS spectra
Each complex had its own fragmentation pattern in
FAB-MS spectroscopy; Table 1 collects relevant data that
conﬁrmed the existence of ligand–metal species.
Only for Cu–L3 the molecular ion species ([Cu(L–H)2]
+)
can be observed showing the corresponding pattern of two
chlorine atoms and one copper in the molecule. Besides, it
is observed the loss of oxygen, typical behavior for N-oxide
containing heterocycles. All three complexes present a frag-
ment that corresponds to one copper coordinated to one
ligand ([Cu(L–H)]+, as well as another fragment corre-
sponding to the ligand. Furthermore, in the case of Cu–
L1 and Cu–L2 some fragments conﬁrm the coordination
through the N! O group, in accordance with the IR data
and the proposed structure shown in Fig. 5.
3.2. Conductimetric and thermogravimetric measurements
Conductimetric measurements in DMF solution of the
complexes showed no signiﬁcant change in the conductivity
in comparison with that of the pure solvent. This behavior
is in agreement with the neutrality of the complexes,
according to the formula assigned. In addition, the conduc-
tivity of DMF and DMSO solutions was measured during
a week and no major changes were observed in either sol-
vent, showing the stability of the complexes in these
solvents.
Thermogravimetric measurements performed with Cu–
L3 at diﬀerent heating rates showed that water release
began at 122 C simultaneously with the rapid degradation
of the ligand. The temperature of the water release is in
Fig. 5. Proposed three-dimensional structure of dimeric complex Cu–L2 calculated with HyperChem (TM) Professional 7.51.
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agreement with the presence of a coordinated water
molecule.
3.3. Stability
The complexes were stable under the experimental con-
ditions. No free ligand spots were observed in any chro-
matogram of the three complexes. Besides, no major
changes on the conductivity of DMSO solutions were
observed. For these reasons we assumed that the complexes
remain stable during the cytotoxic studies.
3.4. Cytotoxic studies
Table 2 shows the results of the cytotoxic studies for
Cu–L1, Cu–L2 and Cu–L3 at 20.0 lM. The three com-
plexes presented signiﬁcantly diﬀerent cytotoxic activities
and consequently these compounds might act with a diﬀer-
ent mechanism of action. Cu–L1 is cytotoxic in normoxia
and hypoxia, therefore the mode of action is independent
from the concentration of oxygen in the cell. On the con-
trary, Cu–L2 is only cytotoxic in hypoxia, therefore the
activity is related to the low level of oxygen concentration.
Cu–L3 is inactive in both conditions probably because it
might not be able to penetrate through the cell membrane
due to its low lipophilicity (see in Section 3.6) or it might be
inactive inside the cell.
According to these results, only Cu–L2 presented selec-
tivity in hypoxia at 20.0 lM. For this reason it was tested
at diﬀerent doses in hypoxic conditions. Data for potency
in hypoxia (P) and hypoxic cytotoxicity ratio (HCR) for
Cu–L2 and the corresponding ligand, L2, are shown in
Table 3. The low solubility of Cu–L2 did not allow us to
obtain the exact value of potency in normoxia. The potency
in normoxia is higher than 40.0 lM while in hypoxic con-
ditions is 20.0 lM.
Although, Cu–L2 showed selective activity in hypoxia it
is less potent than the free ligand. Nevertheless, the potency
in hypoxia of this complex resulted at least similar to that
of Tirapazamine, the ﬁrst bioreductive cytotoxic drug
introduced into clinical trials.
Cu–L2 complex resulted to be as potent as the previ-
ously reported Cu(II) complexes 1 and 2 (Fig. 1)
(P1 = 35.1, P2 = 27.9 lM, [21]). In addition, the HCR
value for this compound is of the same order than the cor-
responding for related vanadyl complexes 4 and 5 previ-
ously described (HCR4 = 15, HCR5 = 15, [20]). In spite
of the fact that there are organic molecules with higher
cytotoxicity in hypoxia [15], Cu–L2 presents a promising
pharmacological proﬁle that could be an interesting start-
ing point for future chemical modiﬁcations in order to
improve the activity.
Another interesting observation is that the electronic
properties of quinoxaline substituents (H, F, Cl, OMe,
Fig. 2) could be related to the potency in hypoxia of the
complexes bearing selective hypoxic cytotoxicity. Trying
Table 1
Characteristic fragments observed in FAB-MS spectroscopy of the complexes
Compound Relative intensity (%)
[Cu(L–H)2]
+ [Cu(L–H)2–X)]
+ [Cu(L–H)]+ L+
Cu–L1 – –X@CN, O 2.0/1.0 3.0 24.0
Cu–L2 – –X = F 3.0/4.0/1.4a 6.0/3.5/2.5b 10.0
–X@3 O, CN 2.0/1.0/0.5a
Cu–L3 2.0/2.0/0.5c –X@O 2.0/2.0/0.5c 9.0/7.0/1.5b 15.0/10.0d
–X@OCH3 4.0/4.0/1.5
c
–X@CN, O 8.0/4.0/2.0c
a Pattern for one copper and two chlorines in the ion’s structure.
b Pattern for one copper and one chlorine in the ion’s structure.
c Pattern for one copper and two chlorines in the ion’s structure.
d Pattern for one chlorine in the ion’s structure.
Table 2
Partition coeﬃcient octanol/physiological serum (P), SOD-like activity
(IC50), and hypoxic and normoxic cytotoxicity on V79 cells for the new
developed copper complexes
Compound P/logP IC50 (lM) Sfnormox
c/SDd Sfhypoxe/SDd
Cu–L1 7.17/0.86 18.0 18/6 1/0
Cu–L2 a 89.0 77/10 1/2
Cu–L3 1.25/0.10 >149.0b 100/1 100/0
a Cu–L2 low physiological serum solubility did not allow determining
this value.
b The complex Cu–L3 was not soluble in the assayed conditions at
higher concentrations than 149.0 lM.
c Sfnormox: survival fraction in normoxia.
d SD: standard deviation.
e Sfhypox: survival fraction in hypoxia.
Table 3
Data of potency in hypoxia (P) and hypoxic citotoxicity ratio (HCR) of
Cu–L2 and L2
Compound P (lM) HCR
L2 2.0 10
Cu–L2 20.0 >2
Tirapazaminea 30.0 75
a Refs. [20,21,25–28].
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to ﬁnd out correlations between selective activity in
hypoxia and structural data, we compared Cu–L2 with
complexes 1 and 2 which were also selective in hypoxia.
For example, the potency for complexes 1, 2 and Cu–L2
can be correlated with the sum of Hammett rm constants
(electronic descriptors of the substituents depending on
their donor–acceptor characteristics) [35,36]. The sum of
Hammet constants was calculated using rm,Cl = 0.37,
rm,Br = 0.39 and rm,H = 0.00 for complexes 1 and 2, and
rm,F = 0.34 and rp,Cl = 0.23 for complex Cu–L2 and tak-
ing into account the substituent relative position in the qui-
noxaline moiety. The Rr are 0.37, 0.39 and 0.57 for
complexes 1, 2 and Cu–L2, respectively. As it can be seen,
compounds with better hypoxic potency, P1 = 35.1,
P2 = 27.9, PCu-L2 = 20.0 lM (lower doses producing 1%
survival fraction in hypoxia) have higher r values due to
the halogen substituents in aromatic cycles.
3.5. Lipophilicity test
Table 2 shows the values of the partition coeﬃcient oct-
anol/physiological serum (P) for the three complexes. Cu–
L3 presented the lower lipophilicity and it was the less cyto-
toxic compound. Probably it could not penetrate through
the cell membrane. The complex Cu–L1 and Cu–L2 are
more lipophilic than Cu–L3 and at the same time more
active.
3.6. SOD-like activity
The Cu(II) concentration required to produce a 50%
inhibition(IC50) of NBT reduction is shown in Table 2.
IC50 for Cu–L3 was not exactly determined due to the fact
that this complex is insoluble in higher concentrations.
IC50 values for Cu–L1 and Cu–L2 were of the same
order than those obtained from copper complexes showing
pharmacological properties associated with the dismuta-
tion of the superoxide radical. For example, pharmacolog-
ically active copper(II) complexes with aminoacids [9]
showed IC50 values in the range 30.3–37.2 lM and
Cu(II)-sulfonamides presented values between 38 and
73 lM, all of which were determined with the same exper-
imental technique [37,38]. An interesting aspect is the rela-
tionship found between the cytotoxic eﬀect in normoxia
and the SOD-like activities (Table 2). The complex Cu–
L1 with the lowest IC50 presented the highest cytotoxicity
in normoxia. This behavior is in accordance with the
hypothesis proposed by Ramadan for several copper com-
plexes where the H2O2 formed by the dismutation of O

2
can be related to the production of reactive radical species
such as the cytotoxic hydroxyl radical OHÆ. Cu–L2 (good
cytotoxic compound in hypoxia) presented lower SOD-like
activity and consequently lower activity in normoxia while
the Cu–L3 was inactive. Obviously no relationship was
observed between hypoxic selectivity and SOD-like
activity.
4. Conclusions
New copper complexes with quinoxaline N1,N4-dioxide
derivatives were synthesized and characterized by diﬀerent
spectroscopic methods and tested for cytotoxicity to V79
cells under hypoxic and aerobic conditions. As the EPR
spectra showed the complexes presented dimeric units in
solid state and in DMSO they became monomeric species.
According to the stability tests the ligands remained coor-
dinated with the copper ion in the DMSO solutions.
Although the complexes are similar only Cu–L2 showed
cytotoxic selectivity in hypoxia and presented the highest
lipophilicity. On the contrary, Cu–L1 was not selective
but showed good proﬁle as cytotoxic agent in normoxia,
being this eﬀect related to its SOD like activity. Cu–L3
was not cytotoxic in the assayed conditions probably due
to its insolubility or its low lipophilicity. In addition, the
potency for the hypoxic selective complexes Cu–L2 and
the previously reported 1 and 2 could be correlated with
the sum of Hammett rm constants, showing that com-
pounds with better hypoxic potency have higher r values
due to the halogen substituents in aromatic rings.
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